Elena Ho

711 total citations
15 papers, 270 citations indexed

About

Elena Ho is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Elena Ho has authored 15 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 6 papers in Molecular Biology and 3 papers in Genetics. Recurrent topics in Elena Ho's work include Blood Coagulation and Thrombosis Mechanisms (7 papers), Hemophilia Treatment and Research (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Elena Ho is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (7 papers), Hemophilia Treatment and Research (7 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Elena Ho collaborates with scholars based in United States, Germany and United Kingdom. Elena Ho's co-authors include Babu Subramanyam, Jih‐Lie Tseng, Gary B. Phillips, Marc Whitlow, Jian-Ming Gu, Marc Adler, James M. Wu, Imadul Islam, John E. Murphy and Mark A. Polokoff and has published in prestigious journals such as Blood, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Elena Ho

15 papers receiving 263 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elena Ho United States	9	122	91	57	34	33	15	270
Lan Trinh United States	11	170 1.4×	59 0.6×	215 3.8×	33 1.0×	50 1.5×	17	381
Lawrence J. Mersinger United States	8	209 1.7×	122 1.3×	116 2.0×	44 1.3×	11 0.3×	9	412
Christopher P. Tinworth United Kingdom	7	306 2.5×	79 0.9×	68 1.2×	21 0.6×	42 1.3×	9	379
Deborah L. Volkots United States	10	163 1.3×	45 0.5×	335 5.9×	20 0.6×	21 0.6×	13	522
Agustin Casimiro‐Garcia United States	12	158 1.3×	30 0.3×	156 2.7×	22 0.6×	48 1.5×	22	368
Victoria G. Klein United States	6	321 2.6×	46 0.5×	81 1.4×	4 0.1×	47 1.4×	7	395
Xavier Pellé Switzerland	6	242 2.0×	51 0.6×	99 1.7×	33 1.0×	60 1.8×	8	324
Daniel Meibom Germany	9	271 2.2×	54 0.6×	56 1.0×	10 0.3×	24 0.7×	14	355
Uwe Trinks Switzerland	7	217 1.8×	38 0.4×	241 4.2×	17 0.5×	17 0.5×	10	414
Wheeseong Lee United States	9	116 1.0×	24 0.3×	131 2.3×	14 0.4×	18 0.5×	9	304

Countries citing papers authored by Elena Ho

Since Specialization

Citations

This map shows the geographic impact of Elena Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Ho more than expected).

Fields of papers citing papers by Elena Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Ho. The network helps show where Elena Ho may publish in the future.

Co-authorship network of co-authors of Elena Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Ho. A scholar is included among the top collaborators of Elena Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Ho. Elena Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Islam, Imadul, Shendong Yuan, Christopher W. West, et al.. (2018). Discovery of selective urokinase plasminogen activator (uPA) inhibitors as a potential treatment for multiple sclerosis. Bioorganic & Medicinal Chemistry Letters. 28(20). 3372–3375. 4 indexed citations

Gu, Jian-Ming, Xiao-Yan Zhao, Thomas Schwarz, et al.. (2017). Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus Monkeys. The AAPS Journal. 19(4). 1186–1195. 36 indexed citations

Leong, Lilley, Derek Sim, Katherine Tran, et al.. (2014). Noncovalent stabilization of the factor VIII A2 domain enhances efficacy in hemophilia A mouse vascular injury models. Blood. 125(2). 392–398. 12 indexed citations

Blasko, Eric, Lilley Leong, Derek Sim, et al.. (2014). Reduced Polyethylene Glycol-Conjugated B-Domain–Deleted Factor VIII (PEG-BDD-FVIII) Clearance: Selective Peg Steric Modulation without Affecting Potency. Blood. 124(21). 1471–1471. 2 indexed citations

Blasko, Eric, et al.. (2013). Hepatocyte clearance and pharmacokinetics of recombinant factor IX glycosylation variants. Biochemical and Biophysical Research Communications. 440(4). 485–489. 8 indexed citations

Blasko, Eric, R I Feldman, Liang Tang, et al.. (2013). Glycoengineered factor IX variants with improved pharmacokinetics and subcutaneous efficacy. Journal of Thrombosis and Haemostasis. 11(9). 1699–1706. 13 indexed citations

Tang, Liang, Lilley Leong, Elena Ho, et al.. (2013). von Willebrand factor contributes to longer half‐life of PEGylated factor VIII in vivo. Haemophilia. 19(4). 539–545. 28 indexed citations

West, Christopher W., Marc Adler, Elena Ho, et al.. (2009). Identification of orally bioavailable, non-amidine inhibitors of Urokinase Plasminogen Activator (uPA). Bioorganic & Medicinal Chemistry Letters. 19(19). 5712–5715. 11 indexed citations

Islam, Imadul, Greg Brown, Judi Bryant, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 2: Optimization of BX-517. Bioorganic & Medicinal Chemistry Letters. 17(14). 3819–3825. 35 indexed citations

10.

Islam, Imadul, Judi Bryant, Monica J. Kochanny, et al.. (2007). Indolinone based phosphoinositide-dependent kinase-1 (PDK1) inhibitors. Part 1: Design, synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 17(14). 3814–3818. 42 indexed citations

11.

Adler, Marc, David D. Davey, Elena Ho, et al.. (2007). 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation. Bioorganic & Medicinal Chemistry Letters. 17(9). 2499–2504. 8 indexed citations

12.

Ho, Elena, et al.. (2004). Measurements of drug–protein binding by using immobilized human serum albumin liquid chromatography–mass spectrometry. Journal of Chromatography B. 809(1). 67–73. 46 indexed citations

13.

Ng, Howard P., Brad O. Buckman, Keith Eagen, et al.. (2002). Design, Synthesis, and Biological Activity of Novel Factor Xa Inhibitors: 4-Aryloxy Substituents of 2,6-Diphenoxypyridines††See ref. 1.. Bioorganic & Medicinal Chemistry. 10(3). 657–666. 6 indexed citations

14.

Phillips, Gary B., William J. Guilford, Brad O. Buckman, et al.. (2002). Design, Synthesis, and Activity of a Novel Series of Factor Xa Inhibitors: Optimization of Arylamidine Groups. Journal of Medicinal Chemistry. 45(12). 2484–2493. 18 indexed citations

15.

Ho, Elena, et al.. (1984). A rapid method for restriction endonuclease analysis of DNA from herpes simplex virus type 2.. PubMed. 83(3). 237–42. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact